Genetic Analysis and Predictive Modeling of COVID-19 Severity in a Hospital-Based Patient Cohort

The COVID-19 pandemic has had a devastating impact, with more than 7 million deaths worldwide. Advanced age and comorbidities partially explain severe cases of the disease, but genetic factors also play a significant role. Genome-wide association studies (GWASs) have been instrumental in identifying...

Full description

Saved in:
Bibliographic Details
Main Authors: Iraide Alloza-Moral, Ane Aldekoa-Etxabe, Raquel Tulloch-Navarro, Ainhoa Fiat-Arriola, Carmen Mar, Eloisa Urrechaga, Cristina Ponga, Isabel Artiga-Folch, Naiara Garcia-Bediaga, Patricia Aspichueta, Cesar Martin, Aitor Zarandona-Garai, Silvia Pérez-Fernández, Eunate Arana-Arri, Juan-Carlos Triviño, Ane Uranga, Pedro-Pablo España, Koen Vandenbroeck-van-Caeckenbergh
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/15/3/393
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850089928435695616
author Iraide Alloza-Moral
Ane Aldekoa-Etxabe
Raquel Tulloch-Navarro
Ainhoa Fiat-Arriola
Carmen Mar
Eloisa Urrechaga
Cristina Ponga
Isabel Artiga-Folch
Naiara Garcia-Bediaga
Patricia Aspichueta
Cesar Martin
Aitor Zarandona-Garai
Silvia Pérez-Fernández
Eunate Arana-Arri
Juan-Carlos Triviño
Ane Uranga
Pedro-Pablo España
Koen Vandenbroeck-van-Caeckenbergh
author_facet Iraide Alloza-Moral
Ane Aldekoa-Etxabe
Raquel Tulloch-Navarro
Ainhoa Fiat-Arriola
Carmen Mar
Eloisa Urrechaga
Cristina Ponga
Isabel Artiga-Folch
Naiara Garcia-Bediaga
Patricia Aspichueta
Cesar Martin
Aitor Zarandona-Garai
Silvia Pérez-Fernández
Eunate Arana-Arri
Juan-Carlos Triviño
Ane Uranga
Pedro-Pablo España
Koen Vandenbroeck-van-Caeckenbergh
author_sort Iraide Alloza-Moral
collection DOAJ
description The COVID-19 pandemic has had a devastating impact, with more than 7 million deaths worldwide. Advanced age and comorbidities partially explain severe cases of the disease, but genetic factors also play a significant role. Genome-wide association studies (GWASs) have been instrumental in identifying loci associated with SARS-CoV-2 infection. Here, we report the results from a >820 K variant GWAS in a COVID-19 patient cohort from the hospitals associated with IIS Biobizkaia. We compared intensive care unit (ICU)-hospitalized patients with non-ICU-hospitalized patients. The GWAS was complemented with an integrated phenotype and genetic modeling analysis using HLA genotypes, a previously identified COVID-19 polygenic risk score (PRS) and clinical data. We identified four variants associated with COVID-19 severity with genome-wide significance (rs58027632 in KIF19; rs736962 in HTRA1; rs77927946 in DMBT1; and rs115020813 in LINC01283). In addition, we designed a multivariate predictive model including HLA, PRS and clinical data which displayed an area under the curve (AUC) value of 0.79. Our results combining human genetic information with clinical data may help to improve risk assessment for the development of a severe outcome of COVID-19.
format Article
id doaj-art-3f818ea942a54f2c841ff4f47f4bb6d3
institution DOAJ
issn 2218-273X
language English
publishDate 2025-03-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj-art-3f818ea942a54f2c841ff4f47f4bb6d32025-08-20T02:42:39ZengMDPI AGBiomolecules2218-273X2025-03-0115339310.3390/biom15030393Genetic Analysis and Predictive Modeling of COVID-19 Severity in a Hospital-Based Patient CohortIraide Alloza-Moral0Ane Aldekoa-Etxabe1Raquel Tulloch-Navarro2Ainhoa Fiat-Arriola3Carmen Mar4Eloisa Urrechaga5Cristina Ponga6Isabel Artiga-Folch7Naiara Garcia-Bediaga8Patricia Aspichueta9Cesar Martin10Aitor Zarandona-Garai11Silvia Pérez-Fernández12Eunate Arana-Arri13Juan-Carlos Triviño14Ane Uranga15Pedro-Pablo España16Koen Vandenbroeck-van-Caeckenbergh17Inflammation & Biomarkers Group, Biobizkaia Health Research Institute, 48903 Barakaldo, SpainInflammation & Biomarkers Group, Biobizkaia Health Research Institute, 48903 Barakaldo, SpainInflammation & Biomarkers Group, Biobizkaia Health Research Institute, 48903 Barakaldo, SpainInflammation & Biomarkers Group, Biobizkaia Health Research Institute, 48903 Barakaldo, SpainPneumology Department, Galdakao-Usansolo University Hospital, Biobizkaia Health Research Institute, 48960 Galdakao, SpainPneumology Department, Galdakao-Usansolo University Hospital, Biobizkaia Health Research Institute, 48960 Galdakao, SpainPneumology Department, Galdakao-Usansolo University Hospital, Biobizkaia Health Research Institute, 48960 Galdakao, SpainInflammation & Biomarkers Group, Biobizkaia Health Research Institute, 48903 Barakaldo, SpainBioinformatic Unit, Biobizkaia Health Research Institute, 48903 Barakaldo, SpainPhysiology Department, Faculty of Medicine and Nursery, Basque Country University (UPV/EHU), 48940 Leioa, SpainInflammation & Biomarkers Group, Biobizkaia Health Research Institute, 48903 Barakaldo, SpainBioinformatic Unit, Biobizkaia Health Research Institute, 48903 Barakaldo, SpainBioinformatic Unit, Biobizkaia Health Research Institute, 48903 Barakaldo, SpainClinical Epidemiology Unit, Biobizkaia Health Research Institute, Cruces University Hospital, Plaza de Cruces s/n, 48903 Barakaldo, SpainBioinformatics Department, Sistemas Genómicos, 46980 Peterna, SpainPneumology Department, Galdakao-Usansolo University Hospital, Biobizkaia Health Research Institute, 48960 Galdakao, SpainPneumology Department, Galdakao-Usansolo University Hospital, Biobizkaia Health Research Institute, 48960 Galdakao, SpainInflammation & Biomarkers Group, Biobizkaia Health Research Institute, 48903 Barakaldo, SpainThe COVID-19 pandemic has had a devastating impact, with more than 7 million deaths worldwide. Advanced age and comorbidities partially explain severe cases of the disease, but genetic factors also play a significant role. Genome-wide association studies (GWASs) have been instrumental in identifying loci associated with SARS-CoV-2 infection. Here, we report the results from a >820 K variant GWAS in a COVID-19 patient cohort from the hospitals associated with IIS Biobizkaia. We compared intensive care unit (ICU)-hospitalized patients with non-ICU-hospitalized patients. The GWAS was complemented with an integrated phenotype and genetic modeling analysis using HLA genotypes, a previously identified COVID-19 polygenic risk score (PRS) and clinical data. We identified four variants associated with COVID-19 severity with genome-wide significance (rs58027632 in KIF19; rs736962 in HTRA1; rs77927946 in DMBT1; and rs115020813 in LINC01283). In addition, we designed a multivariate predictive model including HLA, PRS and clinical data which displayed an area under the curve (AUC) value of 0.79. Our results combining human genetic information with clinical data may help to improve risk assessment for the development of a severe outcome of COVID-19.https://www.mdpi.com/2218-273X/15/3/393SARS-CoV-2GWASCOVID-19severityHLAKIF19
spellingShingle Iraide Alloza-Moral
Ane Aldekoa-Etxabe
Raquel Tulloch-Navarro
Ainhoa Fiat-Arriola
Carmen Mar
Eloisa Urrechaga
Cristina Ponga
Isabel Artiga-Folch
Naiara Garcia-Bediaga
Patricia Aspichueta
Cesar Martin
Aitor Zarandona-Garai
Silvia Pérez-Fernández
Eunate Arana-Arri
Juan-Carlos Triviño
Ane Uranga
Pedro-Pablo España
Koen Vandenbroeck-van-Caeckenbergh
Genetic Analysis and Predictive Modeling of COVID-19 Severity in a Hospital-Based Patient Cohort
Biomolecules
SARS-CoV-2
GWAS
COVID-19
severity
HLA
KIF19
title Genetic Analysis and Predictive Modeling of COVID-19 Severity in a Hospital-Based Patient Cohort
title_full Genetic Analysis and Predictive Modeling of COVID-19 Severity in a Hospital-Based Patient Cohort
title_fullStr Genetic Analysis and Predictive Modeling of COVID-19 Severity in a Hospital-Based Patient Cohort
title_full_unstemmed Genetic Analysis and Predictive Modeling of COVID-19 Severity in a Hospital-Based Patient Cohort
title_short Genetic Analysis and Predictive Modeling of COVID-19 Severity in a Hospital-Based Patient Cohort
title_sort genetic analysis and predictive modeling of covid 19 severity in a hospital based patient cohort
topic SARS-CoV-2
GWAS
COVID-19
severity
HLA
KIF19
url https://www.mdpi.com/2218-273X/15/3/393
work_keys_str_mv AT iraideallozamoral geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT anealdekoaetxabe geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT raqueltullochnavarro geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT ainhoafiatarriola geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT carmenmar geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT eloisaurrechaga geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT cristinaponga geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT isabelartigafolch geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT naiaragarciabediaga geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT patriciaaspichueta geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT cesarmartin geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT aitorzarandonagarai geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT silviaperezfernandez geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT eunatearanaarri geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT juancarlostrivino geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT aneuranga geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT pedropabloespana geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort
AT koenvandenbroeckvancaeckenbergh geneticanalysisandpredictivemodelingofcovid19severityinahospitalbasedpatientcohort